Web Results

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Bruesewitz v. Wyeth Inc. ... Respondent. Wyeth, Inc., fka Wyeth Laboratories, et al . ... defective design. A federal judge dismissed the lawsuit, ruling that the National Childhood Vaccine Injury Act protected Wyeth from lawsuits over vaccine injury claims. The U.S. Court of Appeals for the 3rd Circuit affirmed.

www.courtlistener.com/opinion/1897541/perez-v-wyeth-laboratories-inc

Aug 9, 1999 ... See Perez v. *1249 Wyeth Labs., Inc., 313 N.J.Super. 646, 650, 713 A.2d 588 ( Law Div.1997). The trial court dismissed plaintiffs' complaints, concluding that even when a manufacturer advertises directly to the public, and a woman is influenced by the advertising campaign, "a physician is not simply ...

mdcourts.gov/opinions/coa/2009/112a08.pdf

IN THE COURT OF APPEALS OF. MARYLAND. No. 112. September Term, 2008. PAMELA BLACKWELL et al. v. WYETH d/b/a/ WYETH, INC., et al. Bell, C.J.. Harrell. Battaglia. Greene. Murphy. Adkins. Barbera,. JJ. Opinion by Battaglia, J. Filed: May 7, 2009 ...

biotech.law.lsu.edu/cases/drugs/perez_v_wyeth_laboratories_inc.htm

Wyeth Laboratories Inc., 161 N.J. 1, 734 A.2d 1245 (N.J. 1999). Guide - Perez v. Wyeth Laboratories Inc., 161 N.J. 1, 734 A.2d 1245 (N.J. Aug 09, 1999). [ footnotes have been ..... Charles J. Walsh et al., The Learned Intermediary Doctrine: The Correct Prescription for Drug Labeling, 48 Rutgers L. Rev. 821, 869 (1994). Thus ...

www.ca5.uscourts.gov/opinions%5Cpub%5C12/12-30319-CV0.wpd.pdf

Feb 14, 2013 ... v. PLIVA, INCORPORATED, formerly known as. Pliva USA, Incorporated; TEVA PHARMACEUTICALS. USA, INCORPORATED; ACTAVIS ELIZABETH, L.L.C., as successor ... R.S. 9:2800.51, et seq. We need ... 12-30319. 2 Brand-name manufacturers Wyeth, Inc. and Schwarz Pharma, Inc. were included as.

www.ageofautism.com/2010/07/show-me-that-vaccines-are-safe-the-importance-of-the-supreme-court-bruesewitz-v-wyeth.html

Jul 13, 2010 ... It's with these two principles in mind that I want to discuss Bruesewitz v. Wyeth, Inc., a case headed to the U. S. Supreme Court in September or October of 2010 which will answer the question of whether the National Childhood Vaccine Injury Act of 1986 prevents claimants from bringing an action for ...

www.law360.com/cases/4d2b7c33dbf3b4079a000001

Parties, docket activity and news coverage of federal case USA, ex. rel., Lauren Kieff, et al. v. Wyeth, case number 1:03-cv-12366, from Massachusetts Court.

schachtmanlaw.com/biographical

I was designated as trial counsel for what was to be Pfizer's first case set for trial, in Philadelphia Court of Common Pleas, in 2007 — Coleman v. Wyeth et al. After I argued the motion for summary judgment based upon the statute of limitations, the trial court entered judgment on the eve of trial. Coleman v. Wyeth Pharms.